Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial

Authors

Marie O’Farrell
George Kemble (ORCID: https://orcid.org/0000-0003-4225-8774)
Madhavi Rudraraju
Katharine Grimmer
William McCulloch
Pierre Bédossa (ORCID: https://orcid.org/0000-0002-8487-7322)
Rohit Seth Loomba (ORCID: https://orcid.org/0000-0002-4845-9991)
Eduardo B. Martins (ORCID: https://orcid.org/0000-0003-1947-7784)
Eric Lawitz (ORCID: https://orcid.org/0000-0002-4234-224X)
Stephen A. Harrison (ORCID: https://orcid.org/0000-0001-8285-2204)
Jose Cobiella
Wen-Wei Tsai

Institutions

The University of Texas at San Antonio Health Science Center (US)
University of California San Diego (US)
International Research Associates (United States) (US)
Pinnacle Clinical Research (US)
Texas Liver Institute (US)
Régie Autonome des Transports Parisiens (France) (FR)

Publication Details

Journal: The Lancet. Gastroenterology & hepatology
Published: 2024-10-11
DOI: https://doi.org/10.1016/s2468-1253(24)00246-2
Citations: 78
Primary Topic: Liver Disease Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 30.16

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial

Marie O’Farrell, George Kemble, Madhavi Rudraraju, Katharine Grimmer et al.

Oct 11, 2024

78 citations

The Lancet. Gastroenterology & hepatology

Liver Disease Diagnosis and Treatment

30.16

article

Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial

Marie O’Farrell, George Kemble, Madhavi Rudraraju, Katharine Grimmer, William McCulloch, Pierre Bédossa, Rohit Seth Loomba, Eduardo B. Martins, Eric Lawitz, Stephen A. Harrison, Jose Cobiella, Wen-Wei Tsai

October 11, 2024article en

78 citations

Abstract

No abstract available for this paper.

The Lancet. Gastroenterology & hepatologyVol. 9(12)

The University of Texas at San Antonio Health Science Center (US), University of California San Diego (US), International Research Associates (United States) (US), Pinnacle Clinical Research (US), Texas Liver Institute (US), Régie Autonome des Transports Parisiens (France) (FR)

Good health and well-being

Openalex Percentile: Top 0%

Liver Disease Diagnosis and Treatment

30.16

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.